Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Pignon

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Prognostic value of neural invasion in rectal carcinoma: a multivariate analysis on 339 patients with curative resectionC Bognel, C Rekacewicz, H Mankarios, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinumP Rougier, M Mahjoubi, P Lasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisP Thirion, S Michiels, J P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisP Rougier, M Ducreux, M Mahjoubi, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
British Journal of Cancer|September 19, 2007
Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trialV Boige, J-L Raoul, J-P Pignon, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[What are the real indications for hepatectomies in metastases of colorectal origin?]D Elias, M Ducreux, P Rougier, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialistsR Arriagada, T Le Chevalier, E Quoix, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Prognostic value of neural invasion in rectal carcinoma: a multivariate analysis on 339 patients with curative resectionC Bognel, C Rekacewicz, H Mankarios, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinumP Rougier, M Mahjoubi, P Lasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisP Thirion, S Michiels, J P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisP Rougier, M Ducreux, M Mahjoubi, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
British Journal of Cancer|September 19, 2007
Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trialV Boige, J-L Raoul, J-P Pignon, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[What are the real indications for hepatectomies in metastases of colorectal origin?]D Elias, M Ducreux, P Rougier, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialistsR Arriagada, T Le Chevalier, E Quoix, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Pageof 13